Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2022 ∙ Gombolay, G. Y. Dutt, M. Tyor, W.

Immune responses to SARS-CoV-2 vaccination in multiple sclerosis: a systematic review/meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bidari, A. Asgarian, S. Mohammad, A. P. Naderi, D. Anaraki, S. R. Mesgarha, M. G. Naderkhani, M.

Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ ElSawi, H. A. Elborollosy, A.

Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Roy, A. Verma, N. Singh, S. Pradhan, P. Taneja, S. Singh, M.

Immune-mediated liver injury following COVID-19 vaccination: A systematic review

  • Adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Iheanacho, C. O. Eze, U. I. H.

Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Yin, J. Chen, Y. Li, Y. Wang, C. Zhang, X.

Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis

  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Manothummetha, K. Chuleerarux, N. Sanguankeo, A. Kates, O. S. Hirankarn, N. Thongkam, A. Dioverti-Prono, M. V. Torvorapanit, P. Langsiri, N. Worasilchai, N. Moonla, C. Plongla, R. Garneau, W. M. Chindamporn, A. Nissaisorakarn, P. Thaniyavarn, T. Nematollahi, S. Permpalung, N.

Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2022 ∙ Becerril-Gaitan, A. Vaca-Cartagena, B. F. Ferrigno, A. S. Mesa-Chavez, F. Barrientos-Gutierrez, T. Tagliamento, M. Lambertini, M. Villarreal-Garza, C.

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis

  • Adults
  • Adolescents
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Uaprasert, N. Pitakkitnukun, P. Tangcheewinsirikul, N. Chiasakul, T. Rojnuckarin, P.

Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kang, L. Shang, W. Gao, P. Wang, Y. Liu, J. Liu, M.

Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...